Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional study
Open Access
- 2 June 2008
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 8 (1) , 76
- https://doi.org/10.1186/1471-2334-8-76
Abstract
Human papillomavirus (HPV) is a necessary cause of cervical cancer. HPV is also responsible for benign condylomata acuminata, also known as genital warts. We assessed the incidence of genital warts in Germany and collected information on their management to estimate the annual cost of disease.Keywords
This publication has 17 references indexed in Scilit:
- Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital DiseasesNew England Journal of Medicine, 2007
- Incidence, prise en charge et coût des condylomes acuminés anogénitaux chez les femmes consultant leur gynécologue en FranceGynécologie Obstétrique & Fertilité, 2007
- Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UKCurrent Medical Research and Opinion, 2006
- Results of the First World Health Organization International Collaborative Study of Detection of Human Papillomavirus DNAJournal of Clinical Microbiology, 2006
- Trends in sexually transmitted infections in general practice 1990-2000: population based study using data from the UK general practice research databaseBMJ, 2006
- Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in GermanyPharmacoEconomics, 2005
- The epidemiology of human papillomavirus infectionsPublished by Elsevier ,2005
- European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital wartsSexually Transmitted Infections, 2000
- Epidemiology of Genital Human Papillomavirus InfectionThe American Journal of Medicine, 1997
- Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial NeoplasiaJNCI Journal of the National Cancer Institute, 1993